Oregon judge blocks HHS declaration on youth transgender treatments

A Biden-appointed federal judge in Oregon issued a verbal ruling Thursday blocking a Trump administration HHS declaration that deemed transgender medical procedures for minors unsafe and ineffective. The decision sides with Democratic attorneys general who sued over the December 2025 policy from HHS Secretary Robert F. Kennedy Jr.

This ruling follows a December 2025 lawsuit filed by 19 Democratic-led states and the District of Columbia, led by New York Attorney General Letitia James, challenging an HHS declaration issued by Secretary Robert F. Kennedy Jr. The declaration stated that interventions like puberty blockers, cross-sex hormones, mastectomies, and vaginoplasties for minors 'fail to meet professionally recognized standards of health care' for gender dysphoria.

U.S. District Judge Mustafa Kasubhai, appointed by President Biden, ruled from the bench that the Trump administration did not follow proper procedures under the Administrative Procedure Act. He criticized the approach, saying, 'The notion that “I will go forward and issue a declaration and see if we can get away with it” is not a principle of governance that adheres to the overarching commitment to a democratic republic that requires the rule of law to be regarded and respected and honored as a sacred.' A written decision is forthcoming.

New York AG Letitia James praised the outcome: 'Health care services for transgender young people remain legal, and the federal government cannot intimidate or punish the providers who offer them. It is my duty and my privilege to stand with trans New Yorkers and their families. I will always fight for the LGBTQ+ community.'

The case is part of broader Trump administration actions, including HHS rules excluding providers of such treatments for minors from Medicare and Medicaid, and barring coverage under Medicaid’s Children’s Health Insurance Program for those under 19.

Liittyvät artikkelit

Illustration depicting BOP's new gender dysphoria policy document alongside a federal injunction blocking its enforcement, symbolizing legal tensions over transgender inmate care.
AI:n luoma kuva

Bureau of Prisons adopts new gender dysphoria policy; federal injunction continues to block enforcement

Raportoinut AI AI:n luoma kuva Faktatarkistettu

The U.S. Bureau of Prisons (BOP) issued a new program statement on February 19, 2026, titled “Management of Inmates with Gender Dysphoria,” setting out mental-health “evaluation and treatment” guidelines that describe gender dysphoria as a DSM-5-TR mental health diagnosis and define gender identity as “disconnected from biological reality and sex.” Advocates say the policy would end or restrict gender-affirming hormones and require the removal of gender-affirming personal items, but a federal court order in Kingdom v. Trump has required the BOP to continue providing hormone therapy and certain accommodations while the case proceeds.

The US Supreme Court has issued a preliminary ruling in Mirabelli v. Bonta, reinstating an injunction against California school policies that conceal students' gender transitions from parents. The decision upholds parents' constitutional rights to direct their children's upbringing, particularly in matters affecting mental health like gender dysphoria. The ruling comes amid ongoing debates over parental involvement in schools.

Raportoinut AI

The US Supreme Court ruled 8-1 on Tuesday that Colorado's ban on licensed counselors attempting to change a minor's sexual orientation or gender identity through talk therapy requires strict First Amendment scrutiny. The decision in Chiles v. Salazar, written by Justice Neil Gorsuch, remands the case to lower courts after finding viewpoint discrimination. Justice Ketanji Brown Jackson dissented alone, warning of broad risks to medical regulations.

The U.S. Department of Justice filed a motion on Friday to halt or dismiss a lawsuit by Missouri and other Republican-led states challenging the FDA's policy allowing mifepristone to be shipped through the mail. The filing argues that proceeding with the case would interfere with an ongoing FDA safety review of the drug initiated by the Trump administration. Pro-life advocates have criticized the move, urging stricter regulations on medication abortion.

Raportoinut AI Faktatarkistettu

Two Ohio House Republicans have introduced the “Affirming Families First Act,” which would state that referring to and raising a child in line with the child’s biological sex—such as using a child’s given name and sex-based pronouns—cannot, by itself, be treated as abuse, neglect, or contrary to a child’s best interests in certain custody-related decisions.

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää